183 related articles for article (PubMed ID: 9371090)
1. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant.
Sirawaraporn W; Yongkiettrakul S; Sirawaraporn R; Yuthavong Y; Santi DV
Exp Parasitol; 1997 Nov; 87(3):245-52. PubMed ID: 9371090
[TBL] [Abstract][Full Text] [Related]
2. The role of tryptophan-48 in catalysis and binding of inhibitors of Plasmodium falciparum dihydrofolate reductase.
Kamchonwongpaisan S; Vanichtanankul J; Taweechai S; Chitnumsub P; Yuthavong Y
Int J Parasitol; 2007 Jun; 37(7):787-93. PubMed ID: 17320089
[TBL] [Abstract][Full Text] [Related]
3. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
Hunt SY; Rezvani BB; Sibley CH
Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
5. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
7. A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility.
Japrung D; Chusacultanachai S; Yuvaniyama J; Wilairat P; Yuthavong Y
Protein Eng Des Sel; 2005 Oct; 18(10):457-64. PubMed ID: 16120637
[TBL] [Abstract][Full Text] [Related]
8. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
9. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
Adane L; Patel DS; Bharatam PV
Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
[TBL] [Abstract][Full Text] [Related]
10. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
11. [Gene point mutation in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum].
Zhang ZX; Yang YM; Liu H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):87-9. PubMed ID: 12571992
[TBL] [Abstract][Full Text] [Related]
12. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
16. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
17. Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites.
Bates SJ; Winstanley PA; Watkins WM; Alloueche A; Bwika J; Happi TC; Kremsner PG; Kublin JG; Premji Z; Sibley CH
J Infect Dis; 2004 Nov; 190(10):1783-92. PubMed ID: 15499534
[TBL] [Abstract][Full Text] [Related]
18. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
[TBL] [Abstract][Full Text] [Related]
19. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Cortese JF; Plowe CV
Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
[TBL] [Abstract][Full Text] [Related]
20. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
